Biotechnology Assets SA
MAD:BST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biotechnology Assets SA
MAD:BST
|
ES |
|
Cell MedX Corp
OTC:CMXC
|
US |
|
M
|
Multibax PCL
SET:MBAX
|
TH |
|
P
|
Planet Fitness Inc
F:3PL
|
US |
|
Fiore Gold Ltd
XTSX:F
|
CA |
|
P
|
Philomaxcap AG
F:HBD1
|
DE |
|
Wow Unlimited Media Inc
XTSX:WOW
|
CA |
|
Baron Energy Inc
OTC:BROE
|
US |
|
Kudelski SA
F:KUD
|
CH |
|
B
|
Bersama Mencapai Puncak PT Tbk
IDX:BAIK
|
ID |
|
C
|
Chrysos Corp Ltd
ASX:C79
|
AU |
|
F
|
Foschini Group Ltd
JSE:TFG
|
ZA |
|
I
|
Industrial and Commercial Bank of China Ltd
SWB:ICK
|
CN |
|
Agricultural Bank of China Ltd
SSE:601288
|
CN |
|
Hydrix Ltd
ASX:HYD
|
AU |
|
Athena Gold Corp
OTC:AHNRF
|
US |
|
Altimmune Inc
NASDAQ:ALT
|
US |
|
Polaris Media ASA
OSE:POL
|
NO |
|
Tekmar Group PLC
LSE:TGP
|
UK |
|
A
|
Allegiant Professional Business Services Inc
OTC:APRO
|
US |
|
Elders Ltd
ASX:ELD
|
AU |
|
Zanaga Iron Ore Company Ltd
LSE:ZIOC
|
GG |
|
Oberbank AG
VSE:OBS
|
AT |
|
AI/ML Innovations Inc
OTC:AIMLF
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BST's stock price target?
Not Available
BST does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Biotechnology Assets SA?
Projected CAGR
130%
Over the last 13 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 4 years is 130%.
What is the Gross Profit forecast for Biotechnology Assets SA?
Projected CAGR
591%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 5 years is 591%.